Merck KGaA to acquire Mirus Bio for US$600 million to advance integrated offering for viral vector manufacturing
Acquiring Company
Merck Group
Acquired Company
Mirus Bio
Darmstadt
MadisonManufacturingBiotechnologyHealth CarePharmaceuticalLife ScienceBiotechnologyTherapeuticsDescription
Merck KGaA, a prominent science and technology company, has reached an agreement to acquire Mirus Bio for US$600 million. The acquisition is strategically aimed at advancing Merck KGaA's capabilities in viral vector manufacturing, specifically in the production of cell and gene therapies. This move underscores Merck KGaA's commitment to innovation and growth in the life science sector, enhancing its position as a key player in the industry.
Quick answer
Merck Group is acquiring Mirus Bio for $600 million, announced May 24, 2024. Merck Group is based in Darmstadt, Hesse, Germany.
- How much did Merck Group pay for Mirus Bio?
- The reported deal value is $600 million.
- What does Merck Group do?
- Merck, a leading science and technology company, operates across life science, healthcare and electronics.
- Where are Merck Group and Mirus Bio based?
- Merck Group is based in Darmstadt, Hesse, Germany. Mirus Bio is based in Madison, Wisconsin, United States.
- Who are the decision-makers at Merck Group?
- Fundz holds 2 contacts at Merck Group. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Life Science
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie finalizes acquisition of Landos Biopharma, Inc. to advance treatment for ulcerative colitis and Crohn's disease (May 23, 2024)
- Nuvation Bio Inc. completes acquisition of AnHeart Therapeutics Ltd. to enhance its oncology pipeline (April 10, 2024)
- Sudeep Pharma promoters regain 100% ownership by acquiring 50% shares from JRS Pharma (July 8, 2024)
- Cycle Pharmaceuticals proposes to acquire Vanda Pharmaceuticals for $8.00 per share (June 6, 2024)
- LCI completes acquisition of certain assets of Pfizer Pakistan Limited and Pfizer Inc. to enhance pharmaceutical portfolio (May 20, 2024)
- Eli Lilly and Company acquires manufacturing facility from Nexus Pharmaceuticals to expand U.S. capacity (April 22, 2024)
Who to call at Merck Group, and when
When Merck Group changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Merck Group raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Merck Group, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Merck Group. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Merck Group makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Mirus Bio?
Mirus Bio was acquired by Merck Group, based in Darmstadt. The deal was reported on May 27, 2024. Merck, a leading science and technology company, operates across life science, healthcare and electronics. Merck Group is privately held and operates in Manufacturing.
When did Merck Group acquire Mirus Bio?
Merck Group's acquisition of Mirus Bio was reported on May 27, 2024. Merck KGaA, a prominent science and technology company, has reached an agreement to acquire Mirus Bio for US$600 million. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Mirus Bio do?
Mirus Bio, part of Gamma Biosciences, is a life science company based in Madison, Wisconsin, USA, that specializes in the development and commercialization of transfection reagents, such as TransIT-VirusGEN®. It is privately held, operating in Biotechnology, and is based in Madison.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.